The chemical class of MRGF activators consists of specialized compounds that are designed to enhance the functional activity of the MRGF protein. These activators work by binding to the MRGF protein in a manner that increases its biological activity, leading to the upregulation of its physiological effects. The development of these chemical activators is rooted in a comprehensive understanding of the protein's structure and the specific mechanisms through which it exerts its function. Through targeted interactions, MRGF activators can induce conformational changes in the protein structure or stabilize the active form of the protein, thereby promoting its engagement in cellular processes. The discovery and optimization of these activators involve a combination of computational modeling, molecular biology techniques, and pharmacological assays to identify compounds that exhibit potent and selective activation of the MRGF protein.
The process of creating MRGF activators is intricate and requires a multidisciplinary approach. It begins with the identification of potential compounds through screening libraries of small molecules or designing molecules based on the protein's active site architecture. Following identification, these compounds undergo rigorous testing in vitro and in cell-based systems to evaluate their ability to activate the MRGF protein effectively. This phase includes assessing the specificity of the interaction, the potency of activation, and the determination of the kinetic parameters associated with the activation process. Subsequent stages involve chemical optimization to improve the pharmacological properties of the lead compounds, including their solubility, stability, bioavailability, and safety profile. The goal of developing MRGF activators is to provide valuable tools for research into the biological roles of MRGF. By enhancing the activity of the MRGF protein, these chemical activators open new pathways for investigating the physiological and pathological processes in which MRGF is involved.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid might enhance gene expression by activating nuclear receptors that bind to the MRGPRF promoter region. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin could raise cAMP levels, which might lead to the activation of transcription factors that upregulate MRGPRF expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
Beta-Estradiol might interact with estrogen receptors, potentially causing an upregulation of various GPCRs including MRGPRF. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
This DNA methyltransferase inhibitor may demethylate DNA and induce gene expression by promoting a more open chromatin state. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As an HDAC inhibitor, it can enhance gene expression by increasing histone acetylation and transcriptional activity. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
It may modulate gene expression through its nuclear receptor, which binds to vitamin D response elements in gene promoters. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
This HDAC inhibitor could induce gene expression by causing hyperacetylation of histones, affecting gene transcription. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin may indirectly upregulate MRGPRF expression by inducing cellular stress responses that affect gene regulation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may activate sirtuins, leading to deacetylation of transcription factors and altered gene expression patterns. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
It affects the GSK-3 pathway, which might lead to changes in the nuclear translocation of transcription factors. | ||||||